ホーム>>Signaling Pathways>> Metabolism>> Necroptosis>>Necrostatin-1 Inactive Control

Necrostatin-1 Inactive Control (Synonyms: Nec-1i)

カタログ番号GC40497

Necrostatin-1 Inactive Control(Nec-1i)は、RIP1キナーゼ阻害剤であるネクロスタチン-1の脱メチル化変異体です。

Products are for research use only. Not for human use. We do not sell to patients.

Necrostatin-1 Inactive Control 化学構造

Cas No.: 64419-92-7

サイズ 価格 在庫数 個数
1mg
$43.00
在庫あり
5mg
$150.00
在庫あり
10mg
$280.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Necrostatin-1 Inactive Control (Nec-1i) is a demethylated variant of necrostatin-1, a RIP1 kinase inhibitor.[1] While both Nec-1 and Nec-1i inhibit the immune regulator indoleamine 2,3-dioxygenase, Nec1i is ~ 100-fold less effective than Nec-1 in inhibiting RIP1 kinase in vitro and 10-fold less potent than Nec-1 in a mouse necroptosis assay.[2] However, equally high doses of Nec-1 and Nec-1i are reported to inhibit TNF-induced systemic inflammatory response syndrome in vivo.[2] Nec-1i is often used as an inactive control in studies using Nec-1 to exclude nonspecific off-target effects.

Reference:
[1]. Degterev, A., Hitomi, J., Germscheid, M., et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nature Chemical Biology 4(5), 313-321 (2008).
[2]. Takahashi, N., Duprez, L., Grootjans, S., et al. Necrostatin-1 analogues: Critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis. 3, e437 (2012).

レビュー

Review for Necrostatin-1 Inactive Control

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Necrostatin-1 Inactive Control

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.